CANCER ANTIGENS - OTHER

Primary DI

06974671100106

Basic UDI-DI Code

B-06974671100106

Reference

DR-CM-A019

Device Types

None provided

Regulation

Eu Ivdd

Classification

Eu Ivd General

Status

On The Market

Manufacturer

Darui Biotechnology Co., Ltd.

This kit is intended for quantitative detection of carcinoembryonic antigen (CEA) and alpha-fetoprotein (AFP) in human serum. It is mainly used for dynamic monitoring of patients with malignant tumors to assist in evaluating disease progression or treatment effects. It should not be used as the basis for the early diagnosis or confirmation of malignant tumors or used for tumor screening in the general population. This kit can be used to determine the level of tumor markers such as CEA and AFP that require dynamic monitoring in the treatment of patients with malignant tumors and to monitor the treatment of patients.

Other on-the-market devices with the same classification (Eu Ivd General) and regulation (EU IVDD).